Faruqi & Faruqi, LLP is Investigating Keryx Biopharmaceuticals, Inc. (KERX) on Behalf of its Shareholders
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at Keryx Biopharmaceuticals, Inc. ("Keryx " or the "Company") (Nasdaq: KERX).
If you currently own Keryx stock and have continuously owned Keryx stock and would like to discuss your legal rights, please visit www.faruqilaw.com/KERX. You can also contact us by calling Nadeem Faruqi toll free at (212) 983-9330 or by sending an e-mail to email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Keryx’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you. If you want to be a Lead Plaintiff or join
this action now, please click HERE.
* The submission of this form does not create an attorney-client relationship.
Faruqi & Faruqi, LLP
369 Lexington Avenue 10th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.